Recent Headlines
Within Drug Delivery Systems
Dr. Kristy Ainslie Strengthens Drug Delivery Focus as She Becomes Advisor to Peptineo
Peptineo is pleased to welcome Dr. Ainslie to advisory board at Peptineo. Dr. Ainslie received her PhD in Chemical Engineering from Penn State, and after a short post doc in a start up company focused on biosensor development, Protiveris, she completed a post doc at UCSF. During her post doc, she... - April 08, 2014 - Peptineo
Dr. Applegate to Join Advisory Board at Peptineo
Peptineo is pleased to welcome Dr. Robert Applegate to the advisory board of Peptineo. Dr. Applegate is a recognized expert in microfluidics, biomedical devices and optical technologies. As a result of his research, Dr. Applegate holds patents in optical trapping, cell diagnostics and sorting, and... - April 07, 2014 - Peptineo
Peptineo, a Biotechnology Company Focused on Value Recovery in Pharma, Announces the Appointment of Kamal Garcha PhD., to Advisory Board
"We welcome the addition of Dr. Garcha," noted Sheldon K. Jordan, PhD, CEO. Dr. Garcha holds an Honor’s BSC in Cell Biology and MSc. in Zoology from Western University, and a PhD. in Cellular & Physiological Sciences from the University of British Columbia. During the course of... - April 02, 2014 - Peptineo
Peptineo Adds Dr. Yoganathan to Advisory Board to Strengthen Biomaterials Development and Commercialization
Dr. Yoganathan is a SME in the areas of biomaterials and drug delivery - having collaborated and worked closely with thought-leaders in the field such as Dr. Robert Langer, Dr. Kazunori Kataoka, Dr. Michael V. Sefton and Dr. Christine Allen. He is an expert in manipulating material properties to... - March 31, 2014 - Peptineo
Summit Biosciences Announces Successful FDA Preapproval Inspection for Manufacturing of Nasal Spray Drug Product
Summit Biosciences Inc., a specialty pharmaceutical company, is pleased to announce that the manufacturing facility in Lexington, Kentucky has successfully passed its first preapproval inspection by the Food and Drug Administration (FDA). The inspection for a new nasal spray drug product, which... - March 28, 2014 - Summit Biosciences Inc.
Peptineo Announces Appointment of David M. Wyatt to Advisory Board
Peptineo is pleased to announce the appointment of David M. Wyatt to their advisory board. David has had over 25 years of technical and business experience in the development of controlled release pharmaceutical products. He has held senior management positions in sales and business development,... - March 27, 2014 - Peptineo
Dr. Sundar Nadarajan Joins the Advisory Board at Peptineo to Guide Nanotechnology Drug Delivery Platform for Protein Therapeutics
Sheldon K. Jordan, PhD, President and CEO, Peptineo, announces the appointment of Sundar Nadarajan, PhD, to the company's Scientific Advisory Board. They are extremely pleased that Dr. Nadarajan has joined the Peptineo Scientific Advisory Board. "He is an accomplished scientist and consulting... - March 27, 2014 - Peptineo
Creative Biomart Launches New Services: Protein Labeling & Conjugation
Creative Biomart has announced the launch of a new offering for protein labeling and conjugation. - March 13, 2014 - Creative Biomart
Dr. George Tegos Joins Advisory Board at Peptineo to Guide Antimicrobial Pipeline and Technology Development
Peptineo, a biotechnology company focused on value recovery in Pharma, announces the appointment of George Tegos, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Tegos has joined the Peptineo Scientific Advisory Board. Dr. Tegos is recognized as an emerging... - January 29, 2014 - Peptineo
Dr. Eric Bachelder Joins Advisory Board at Peptineo
Sheldon K. Jordan, PhD, President and CEO, Peptineo, announces the appointment of Eric Bachelder, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Bachelder has joined the Peptineo Scientific Advisory Board. Dr. Bachelder is recognized as an emerging... - January 18, 2014 - Peptineo
Kimberley Beauford Joins Peptineo as Vice President of Human Capital
Industry veteran and accomplished executive, Kimberley Beauford has joined Peptineo as its new vice president of human capital. Beauford brings over 14 years of proven expertise in the delivery of innovative, strategic human capital programs to the finance and healthcare industries. Prior to... - January 14, 2014 - Peptineo
Creative Biomart Releases New Recombinant Protein Products-Human MET Mutants
Creative Biomart announces that it has launched a series of new recombinant human MET mutants. - January 11, 2014 - Creative Biomart
Kaygee Loparex India Pvt. Limited Awarded Integrated Management Systems (IMS) Certification by LRQA
Kaygee Loparex India, leading manufacturer of Silicone Coated Release Liner products has been awarded the prestigious IMS certification for demonstrating its commitment to Quality, Environment, and Occupational Health & Safety Management Systems. This certification has been awarded to the... - January 10, 2014 - Kaygee Loparex India Pvt Limited
Peptineo Inks Exclusive Option for Drug Delivery Technologies
Peptineo, a privately held biotechnology company, announced today that the company has inked an exclusive option for a broad set of nanotechnology patents in the area of drug delivery. Under this agreement, Peptineo will work to commercialize drug delivery technologies developed in the laboratories... - December 10, 2013 - Peptineo
Creative Biomart Introduces New Elisa Kits to Offer More Convenient and Effective Solutions
In the early November, Creative Biomart decided to introduce new Elisa Kits which include Developmental proteins ELISA kits, Granzymes and perforins ELISA kits and Growth factors/hormones ELISA kits. - November 20, 2013 - Creative Biomart
Creative Biomart Decides to Pump $300 Million to Strengthen Biosimilar Cell Lines Production
Today on the annual department meeting, Creative BioMart announces that it plans to invest more than $300 million to strengthen its biosimilar cell lines production in global range. The domain sectors of Creative BioMart are recombinant proteins, antibodies and enzymes. Several years ago, the... - November 17, 2013 - Creative Biomart
Creative Biomart Announces Commercial Agreement for Services of Biosimilar Cell Lines Manufacturing
Creative Biomart announced today that it has signed a commercial agreement for contract manufacturing pharmaceutical biosimilar cell lines for a big pharma company. - November 10, 2013 - Creative Biomart
Creative Biomart Releases New Products in the Middle of Oct.
In the middle of Oct., Creative Biomart releases a new batch a products, including: Ÿ Recombinant Human MUSK, GST-tagged Ÿ Recombinant Human TIRAP, His-tagged Ÿ Native Mouse Hb Ÿ Recombinant Human NCAM2, GST-tagged Ÿ Recombinant Human NBPF15, His-tagged Ÿ Recombinant... - October 19, 2013 - Creative Biomart
Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory
After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative Biomart
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis
Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.
Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions
The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative Biomart
Creative Biomart Releases New Antibody Products—Nanobodies
Creative Biomart releases new antibody products, nanobodies, recently. Compared to conventional antibodies, nanobodies also integrate the features of small molecules. - August 18, 2013 - Creative Biomart
Cheers: Researchers Identified New Brain Markers with Creative Biomart’s S100B Antibody
In the study, researchers used the critical products purchased from Creative Biomart. During the process, the serum levels of molecular markers were determined by ELISA using antibodies and antigens from Creative Biomart (New York, NY) (S100B) which you can see in the article. - August 16, 2013 - Creative Biomart
Experts from Creative Biomart Share the Experience on Using Elisa Kits to Improve the Precision of an Assay
There are some issues that researchers might meet in the process of using ELISA Kits. In order to help improve the precision of an assay, Creative Biomart (http://www.creativebiomart.net/) experts concluded the following tips for reference. - August 14, 2013 - Creative Biomart
Research Antibody Survey: Creative Biomart Conducted a Survey Among Antibodies Users
In order to direct market and perfect products, Creative Biomart conducted the survey. And the survey results are listed as follows. - August 03, 2013 - Creative Biomart
Creative Biomart Launched Novel Animal-free Recombinant Proteins for Stable Research
The novel animal-free protein production system is more efficient, fast, flexible and cheap compared to transgenic plants recombinant proteins production; the scaling-up compared with bio-reactors is simple and lineal. It doesn't have issues with inclusion bodies as E.coli. - June 28, 2013 - Creative Biomart
NanCogenics Reports Research Findings on Tumor-Localization of Cancer Therapeutics
Research results on the use of magnetic nanovectors for the tumor-specific localization of cancer therapeutics is discussed. - June 08, 2013 - NanCogenics Inc
Creative Biomart Scientists Found That Shutdown Gene Arih2 May Treat Hepatitis
Arih2 was found within the sentinel dendritic cells of the immune system, which play a vital role in defending intruders. - May 31, 2013 - Creative Biomart
Creative BioMart Funded Research Found Another Anticancer Strategy - Targeting Cyclin D
Researchers successfully silenced abnormal proteins that control cells' growth cycle. - May 10, 2013 - Creative Biomart
GenScript Upgrade Free Bioinformatics Tools
GenScript provides a comprehensive range of online bioinformatics tools for Molecular Biology, Peptide, and Protein Researchers，as well as many other common bioinformatics tools. - February 23, 2013 - GenScript USA Inc.
GenScript Launches eBlot® Protein Transfer System
GenScript USA Incorporation has launched the eBlot® Protein Transfer System, a semi-dry electric blotter for transferring proteins from mini polyacrylamide gels onto membranes in 7 to 10 minutes, expanding its bench-top tool offerings for protein analysis. This system simplifies the process further by including a complete line of accessories, eliminating the need for additional buffers. - February 07, 2013 - GenScript USA Inc.
GenScript Launches New PolyExpress Package
With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods. - February 03, 2013 - GenScript USA Inc.
ProteinSignal - A New Brand of GenScript, Focused on Protein Research
ProteinSignal will serve as a pioneering developer and supplier of high performance protein research products covering the entire protein analysis workflow. Their offerings include cytokines and growth factors, protein purification resins, precast PAGE gels, protein standards, gel staining systems, anti-tag antibodies, western blot detection, ELISA kits and endotoxin detection and removal kits. - January 27, 2013 - GenScript USA Inc.
SignaBlok Awarded NCI Grant to Test New Approach to Lung Cancer Treatment
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Cancer Institute (NCI) to develop novel and first-in-class agents in lung cancer. - October 03, 2012 - SignaBlok, Inc.
SignaBlok Awarded NIH Grant to Develop New Nanotechnology for Diagnostic Imaging of Atherosclerosis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Institutes of Health (NIH) to develop multifunctional nanoformulations for diagnostic imaging of atherosclerosis. - July 12, 2012 - SignaBlok, Inc.
GenScript Launches a Premier Gene Synthesis Service "Gene-Bricktm" for Building Large DNA FragmentsTM
The Gene-BrickTM premier gene synthesis service is specifically designed to meet demands of large DNA fragments which are used in synthetic biology research, such as the building of large genetic circuits and synthetic chromosomes. - June 14, 2012 - GenScript USA Inc.
Nanocopoeia, an Innovative Leader in Particle-Based Therapeutics, is Pleased to Announce the Launch of Its Newly Redesigned Website
Nanocopoeia, Inc., a rapidly-growing nanotechnology company based in St. Paul, has launched its new corporate website, www.nanocopoeia.com. The new website provides detailed information on the applications and benefits of Nanocopoeia’s patented ElectroNanospray™ platform (ENS), a one... - June 01, 2012 - Nanocopoeia, Inc
Navinode to Launch World’s First All-Carbon Fibre Yacht at the Gold Coast Boat Show 2012 in Hong Kong
Navinode and Delta Powerboats will be launching the world’s first all-carbon fibre yacht in serial production in Asia at the Gold Coast Boat Show 2012 in Hong Kong. - April 01, 2012 - SHL Group (Scandinavian Health Group Ltd)
World Leaders to Address Challenges and Technology Breakthroughs in Sample Preparation for Pathogen Detection at 5th Sample Prep Conference in San Diego, May 3-4
Leading organizations from around the world will convene in San Diego for the Knowledge Foundation’s 5th Sample Prep conference which will take place at the Hilton Resort & Spa from May 3-4, 2012. - March 24, 2012 - Knowledge Foundation
GenScript Was the Most Frequently Referred Biology Contract Research Organization by Peer-Reviewed Journal Articles in 2011
GenScript USA Inc., an internationally recognized biology contract research organization (CRO), became the most frequently referred biology CRO in the world by peer-reviewed journal articles in the year 2011. Ever since its inception from 2002, GenScript has been consistently providing biological... - February 03, 2012 - GenScript USA Inc.
SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.
Introducing SHL’s first White Paper: “Auto Injectors: From Planning to Launch”
SHL is introducing the company’s first White Paper on autoinjectors with the goal of sharing with readers insights on how to prepare for the overall project. - January 05, 2012 - SHL Group (Scandinavian Health Group Ltd)
GenScript Launches Rush Gene Synthesis Service
Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in the global market. - December 27, 2011 - GenScript USA Inc.
GenScript Sponsors 2011 iGEM Undergraduate Synthetic Biology Competition
Internationally recognized biology contract research organization GenScript USA Inc. congratulates the achievements of eight teams they sponsored in 2011 iGEM undergraduate synthetic biology competition. The iGEM teams have utilized GenScript’s gene synthesis service to build novel... - December 17, 2011 - GenScript USA Inc.
SHL Receives Great Response at the 2011 PDA in Basel
SHL successfully wrapped exhibition at the PDA’s "The Universe of Pre-filled Syringes and Injection Devices” event. - December 14, 2011 - SHL Group (Scandinavian Health Group Ltd)
SHL to Speak and Exhibit at the 2011 PDA Conference in Basel, Switzerland
SHL will be exhibiting at the 2011 Parental Drug Association (PDA) Europe Conference in Basel, Switzerland November 8-9th at booth #44 & 49. - November 03, 2011 - SHL Group (Scandinavian Health Group Ltd)
SHL Receives Good Design Award for Molly Auto Injector
SHL Molly auto injector receives Good Design Award for its innovative design and related business model. - October 05, 2011 - SHL Group (Scandinavian Health Group Ltd)
Bencos Releases Bencos Shop Beta– Online Procurement System
Bencos Shop will enable all its users to place procurement requests for products & services for life sciences research. - September 12, 2011 - Bencos Research Solutions
Introducing an Optimized Process Management Concept from Drug Development to Drug Manufacturability: Advaceutics®
Reducing risk, defining time lines and increasing cost efficiency on a new drug’s way to commercial scale manufacturing. - August 26, 2011 - ProJect Pharmaceutics GmbH
CannaLicense Has a New Corporate Office in Denver
The medical marijuana licensing center, Cannalicense has announced the opening of their new corporate office in Denver, Colorado. The new corporate office is located at 2250 S Oneida Street, Suite 306. This change is in response to the increase in applicants since the approval for medical marijuana... - August 19, 2011 - CannaLicense